Verastem Inc (USD)
VSTM
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range2.41 | 2.47
52-Wk Range- | -
Last Close2.35
Mkt Cap (m)398.97
Dividend yield-
ISINUS92337C1045
Volume110.00
Exchange VenueNAS

Company Profile

Verastem Inc is a biopharmaceutical company engaged in discovering and developing drugs to improve outcomes for patients with cancer. Its product candidates include duvelisib and defactinib.

Key Information
Price/Earning-
Price/Book3.07
Price/Sales3.33
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 27/04/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.verastem.com

Financials

Income Statement
USD201520162017201820192020
Revenue (m)0.000.000.0026.7217.46-
Operating Income (m)-58.20-37.00-67.80-94.78-132.34-
Net Income (m)-57.87-36.44-67.80-72.43-149.21-
Basic EPS-1.61-0.99-1.76-1.12-2.00-
Avg. Diluted Shares Outstanding (m)35.9336.9938.4269.3274.58-
Balance Sheet
USD201520162017201820192020
Current Assets (m)110.8481.3087.79253.2684.96-
Non Current Assets (m)2.252.332.0023.9860.09-
Total Assets (m)113.0983.6389.79277.24145.05-
Current Liabilities (m)10.1110.9917.1337.0829.89-
Total Liabilities (m)------
Total Equity (m)102.4772.3057.68124.307.17-
Cash Flows
USD201520162017201820192020
Operating Cash Flows (m)-45.56-29.48-57.31-74.52-138.52-
Capital Expenditure (m)-0.21-0.04--23.51-0.01-
Figures are quoted in USD unless stated otherwise
0.09 (3.83%)
$
2.44
Last Price